With extensive experience of our regulatory team, Creative Biolabs provides pre-IND meeting, IND publishing and submission to help gain IND approval to facilitate clinical trials of your drug candidate. We are committed to providing efficient, professional and cost-effective IND publishing and submission service to help our clients to achieve their goals.
Creative Biolabs can provide the following end-to-end IND services from the initial registration and dossier publishing to final submission. We aim to smooth your IND approval and promote your drug development.
To support the dossier package submission across the globe, Creative Biolabs is dedicated to comprehensive services of global regulatory publishing and submission formats including electronic Common Technical Document (eCTD), non-eCTD and paper. We offer document compilation and publishing, and dossier dispatches through specific regulatory publishing and submission software. Adhering to various regulatory guidelines, Creative Biolabs is your trusted partner for multiple submissions within agreed timelines, which has proven to be cost-effective.
With an expert regulatory publishing and submission team, Creative Biolabs caters value-added support for dossier package submission both in paper as well as CTD formats. We decode region specific technicalities to streamline submissions. Please contact us for more information and a detailed quote.
For lab research only, cannot be used for any clinical use.